Paul has over 30 years of experience in alternative investments, business development, corporate strategy and advisory roles gained in the USA, Canada, and Europe. Paul is a Managing Director with Kirchner Group, a traditional merchant banking firm.
Most recently, he was the Executive Vice President of the Business Development Bank of Canada, responsible for its Venture Capital business (BDC VC). BDC VC has over $1 billion in current and planned investments in both Direct investing into technology based companies and Indirect fund of funds investing into technology focused funds. Prior to that, he was the Managing Director of Healthcare Funds for Drug Royalty Corporation (now DRI Capital) which deployed approximately $1 billion in royalty acquisitions with excellent returns. He also has held the global Business Development position for the world’s largest vaccine company, Aventis Pasteur.
He serves on the Advisory Council of the International Centre for Healthcare Innovation. He previously has served on the Board of Osteoporosis Canada, and of various public and private companies.
Paul has a BA from the University of Toronto where his thesis was ‘Nationalism and the Multinational Corporation’ and an MBA from the Ivey School of Business at Western University where he was awarded an academic scholarship for ‘International Business’.